Patient Insights to Improve Naloxone Access and Decision Support

INTRODUCTION: Increased access to naloxone has contributed to reductions in opioid-related overdose. However, many individuals prescribed naloxone do not fill their prescription. Better understanding modifiable patient-level barriers to naloxone receipt may inform health system-level implementation strategies that improve naloxone availability. METHODS: tests for categorical variables and analysis of variance for continuous variables, the authors compared individuals who filled vs did not fill a naloxone prescription. RESULTS: A total of 481 responses were received (19% response rate). More than half (57.5%) of respondents reported not obtaining naloxone at a pharmacy or other community resource. Primary reasons included: perceived lack of need (55.3%), unawareness of practitioner recommendation (14.9%), uncertainty about its purpose (13.1%), cost concerns (7.3%), and unfamiliarity with naloxone (4.4%). Fewer than 10 respondents cited logistical barriers. DISCUSSION: Results from this quality improvement survey are consistent with previous studies of barriers to naloxone use. Among patients who did not fill a prescription for naloxone, many did not assess their personal risk of overdose to be high, and some resented a perceived implication that they might be abusing opioids. Others were unaware that a naloxone prescription was written until notified by a pharmacist. Cost and logistical barriers were less common concerns, each for less than 10% of those not filling a prescription. CONCLUSION: Clear, nonjudgmental communication about the risk for opioid-related overdose, even among people using their opioids appropriately, and education about the purpose of naloxone may improve access.